Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros




Base de datos
Asunto de la revista
Intervalo de año de publicación
1.
Behav Brain Res ; 320: 282-290, 2017 03 01.
Artículo en Inglés | MEDLINE | ID: mdl-27993694

RESUMEN

Methamphetamine (MA) studies in animals usually involve acute, binge, or short-term exposure to the drug. However, addicts take substantial amounts of MA for extended periods of time. Here we wished to study the effects of MA exposure on brain and behavior, using an animal model analogous to this pattern of MA intake. MA doses, 4 and 8mg/kg/day, were based on previously reported average daily freely available MA self-administration levels. We examined the effects of 16 week MA treatment on psychomotor and cognitive function in the rat using open field and novel object recognition tests and we studied the adaptations of the dopaminergic system, using in vitro and in vivo receptor imaging. We show that chronic MA treatment, at doses that correspond to the average daily freely available self-administration levels in the rat, disorganizes open field activity, impairs alert exploratory behavior and anxiety-like state, and downregulates dopamine transporter in the striatum. Under these treatment conditions, dopamine terminal functional integrity in the nucleus accumbens is also affected. In addition, lower dopamine D1 receptor binding density, and, to a smaller degree, lower dopamine D2 receptor binding density were observed. Potential mechanisms related to these alterations are discussed.


Asunto(s)
Encéfalo/efectos de los fármacos , Estimulantes del Sistema Nervioso Central/farmacología , Cognición/efectos de los fármacos , Dopamina/metabolismo , Metanfetamina/farmacología , Desempeño Psicomotor/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Animales , Ansiedad/inducido químicamente , Benzazepinas/farmacología , Peso Corporal/efectos de los fármacos , Encéfalo/diagnóstico por imagen , Isótopos de Carbono/farmacocinética , Antagonistas de Dopamina/farmacología , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática/metabolismo , Conducta Exploratoria/efectos de los fármacos , Masculino , Racloprida/farmacocinética , Ratas , Ratas Sprague-Dawley , Receptores Dopaminérgicos/metabolismo , Reconocimiento en Psicología/efectos de los fármacos , Espiperona/farmacología
2.
Neuroimage ; 59(2): 1508-13, 2012 Jan 16.
Artículo en Inglés | MEDLINE | ID: mdl-21889993

RESUMEN

Deficits in dopamine D2/D3 receptor (D2R/D3R) binding availability using PET imaging have been reported in obese humans and rodents. Similar deficits have been reported in cocaine-addicts and cocaine-exposed primates. We found that D2R/D3R binding availability negatively correlated with measures of body weight at the time of scan (ventral striatum), at 1 (ventral striatum) and 2 months (dorsal and ventral striatum) post scan in rats. Cocaine preference was negatively correlated with D2R/D3R binding availability 2 months (ventral striatum) post scan. Our findings suggest that inherent deficits in striatal D2R/D3R signaling are related to obesity and drug addiction susceptibility and that ventral and dorsal striatum serve dissociable roles in maintaining weight gain and cocaine preference. Measuring D2R/D3R binding availability provides a way for assessing susceptibility to weight gain and cocaine abuse in rodents and given the translational nature of PET imaging, potentially primates and humans.


Asunto(s)
Peso Corporal/fisiología , Cocaína/administración & dosificación , Cuerpo Estriado/metabolismo , Preferencias Alimentarias/fisiología , Tomografía de Emisión de Positrones/métodos , Racloprida/farmacocinética , Receptores Dopaminérgicos/metabolismo , Administración Oral , Animales , Cuerpo Estriado/diagnóstico por imagen , Masculino , Radiofármacos/farmacocinética , Ratas , Ratas Sprague-Dawley
3.
Behav Brain Res ; 217(1): 165-70, 2011 Feb 02.
Artículo en Inglés | MEDLINE | ID: mdl-21034777

RESUMEN

Dopamine (DA) and DA D2 receptors (D2R) have been implicated in obesity and are thought to be involved in the rewarding properties of food. Osborne-Mendel (OM) rats are susceptible to diet induced obesity (DIO) while S5B/P (S5B) rats are resistant when given a high-fat diet. Here we hypothesized that the two strains would differ in high-fat food self-administration (FSA) and that the D2R agonist bromocriptine (BC) would differently affect their behavior. Ad-libitum fed OM and S5B/P rats were tested in a FSA operant chamber and were trained to lever press for high-fat food pellets under a fixed-ratio (FR1) and a progressive ratio (PR) schedule. After sixteen days of PR sessions, rats were treated with three different doses of BC (1, 10 and 20 mg/kg). No significant differences were found between the two strains in the number of active lever presses. BC treatment (10 mg/kg and 20 mg/kg) increased the number of active lever presses (10 mg/kg having the strongest effect) whereas it decreased rat chow intake in the home cage with equivalent effects in both strains. These effects were not observed on the day of BC administration but on the day following its administration. Our results suggest that these two strains have similar motivation for procuring high fat food using this paradigm. BC increased operant responding for high-fat pellets but decreased chow intake in both strains, suggesting that D2R stimulation may have enhanced the motivational drive to procure the fatty food while correspondingly decreasing the intake of regular food. These findings suggest that susceptibility to dietary obesity (prior to the onset of obesity) may not affect operant motivation for a palatable high fat food and that differential susceptibility to obesity may be related to differential sensitivity to D2R stimulation.


Asunto(s)
Bromocriptina/farmacología , Condicionamiento Operante/efectos de los fármacos , Grasas de la Dieta/farmacología , Ingestión de Alimentos/efectos de los fármacos , Animales , Grasas de la Dieta/administración & dosificación , Relación Dosis-Respuesta a Droga , Masculino , Obesidad , Ratas , Ratas Endogámicas , Esquema de Refuerzo , Autoadministración , Especificidad de la Especie
4.
Physiol Behav ; 101(5): 713-8, 2010 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-20801137

RESUMEN

BACKGROUND: Dopamine (DA) and the DA D2 receptor (D2R) are involved in the rewarding and conditioned responses to food and drug rewards. Osborne-Mendel (OM) rats are genetically prone and S5B/P rats are genetically resistant to obesity when fed a high-fat diet. We hypothesized that the differential sensitivity of these two rat strains to natural rewards may also be reflected in sensitivity to drugs of abuse. Therefore, we tested whether OM and S5B/P rats showed a differential preference to cocaine using conditioned place preference (CPP). To also evaluate whether there is specific involvement of the D2R in this differential conditioning sensitivity, we then tested whether the D2R agonist bromocriptine (BC) would differentially affect the effects of cocaine in the two strains. METHODS: OM and S5B/P rats were conditioned with cocaine (5 or 10mg/kg) in one chamber and saline in another for 8days. Rats were then tested for cocaine preference. The effects of BC (0.5, 1, 5, 10, 20mg/kg) on cocaine preference were then assessed in subsequent test sessions. RESULTS: OM rats did not show a significant preference for the cocaine-paired chamber on test day. Only the S5B/P rats showed cocaine CPP. Later treatment with only the highest dose of BC resulted in reduced cocaine CPP in S5B/P rats when treated with 5mg/kg cocaine and in OM rats treated with 10mg/kg cocaine. CONCLUSION: Our results indicated that obesity-resistant S5B rats showed greater cocaine CPP than the obesity-prone OM rats. These findings do not support a theory of common vulnerability for reinforcer preferences (food and cocaine). However, they show that BC reduced cocaine conditioning effects supporting at least a partial regulatory role of D2R in conditioned responses to drugs.


Asunto(s)
Aprendizaje por Asociación/efectos de los fármacos , Cocaína/farmacología , Condicionamiento Psicológico/efectos de los fármacos , Obesidad/genética , Receptores de Dopamina D2/metabolismo , Análisis de Varianza , Animales , Aprendizaje por Asociación/fisiología , Bromocriptina/farmacología , Condicionamiento Psicológico/fisiología , Agonistas de Dopamina/farmacología , Inhibidores de Captación de Dopamina/farmacología , Masculino , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA